rs587782951
From SNPedia
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(A;C) | 5 | Familial hypertrophic cardiomyopathy risk |
(C;C) | 0 | common in clinvar |
Make rs587782951(A;A) |
Reference | GRCh38.p2 38.2/144 |
Chromosome | 20 |
Position | 44160305 |
Gene | JPH2 |
is a | snp |
is | mentioned by |
dbSNP | rs587782951 |
dbSNP (classic) | rs587782951 |
ClinGen | rs587782951 |
ebi | rs587782951 |
HLI | rs587782951 |
Exac | rs587782951 |
Gnomad | rs587782951 |
Varsome | rs587782951 |
LitVar | rs587782951 |
Map | rs587782951 |
PheGenI | rs587782951 |
Biobank | rs587782951 |
1000 genomes | rs587782951 |
hgdp | rs587782951 |
ensembl | rs587782951 |
geneview | rs587782951 |
scholar | rs587782951 |
rs587782951 | |
pharmgkb | rs587782951 |
gwascentral | rs587782951 |
openSNP | rs587782951 |
23andMe | rs587782951 |
SNPshot | rs587782951 |
SNPdbe | rs587782951 |
MSV3d | rs587782951 |
GWAS Ctlg | rs587782951 |
Max Magnitude | 5 |
aka c.482C>A, p.Thr161Lys or T161K
This variant in the JPH2 gene is considered in ClinVar as a variant of uncertain significance with respect to familial hypertrophic cardiomyopathy. However, a 2018 publication based on Finnish patients concludes that the rs58782951(A) mutation is indeed pathogenic for HCM, with a penetrance of 71% by age 60 and 100% by age 80.[PMID 30235249]
ClinVar | |
---|---|
Risk | rs587782951(A;A) |
Alt | rs587782951(A;A) |
Reference | Rs587782951(C;C) |
Significance | Probable-Pathogenic |
Disease | Primary familial hypertrophic cardiomyopathy Hypertrophic cardiomyopathy |
Variation | info |
Gene | JPH2 |
CLNDBN | Primary familial hypertrophic cardiomyopathy Hypertrophic cardiomyopathy |
Reversed | 1 |
HGVS | NC_000020.10:g.42788945G>T |
CLNSRC | |
CLNACC | RCV000143902.3, RCV000466489.1, |